All Minnesotans age 12 and older are now eligible for a COVID-19 vaccine. Accra strongly encourages its employees and clients to be vaccinated for COVID-19 when they are eligible to receive the vaccine. Given our direct support professionals’ role in caring for people with disabilities and the elderly, we feel strongly that keeping our employees and clients safe is paramount – and the vaccine is one of the most important ways to stop the spread of the disease.
Minnesotans who have not received a vaccine can find a vaccination location near them by using the COVID-19 Vaccine Connector. The connector allows users to directly schedule COVID-19 vaccine appointments at the state’s COVID-19 Community Vaccination Program locations. Minnesotans can also contact their healthcare provider, local pharmacy or use the Vaccine Locator Map to search for vaccine providers in their area.
The best protection from COVID-19 will be a combination of getting a COVID-19 vaccine, wearing a mask, staying at least six feet away from others, avoiding crowds, and washing your hands often. No one tool alone is going to stop the pandemic.
FDA approves Pfizer-BioNTech COVID-19 vaccine
On August 23, the U.S. Food and Drug Administration (FDA) approved the Pfizer-BioNTech COVID-19 vaccine for individuals 16 years of age and older. FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. The Pfizer-BioNTech vaccine also continues to be available under emergency use authorization (EUA) for individuals 12 through 15 years of age, and for the administration of a third dose in certain immunocompromised individuals.
CDC recommends additional COVID-19 vaccine dose for moderately to severely immunocompromised people
The CDC is recommending that moderately to severely immunocompromised people receive an additional dose of the COVID-19 vaccine. This includes people who have:
- Been receiving active cancer treatment for tumors or cancers of the blood
- Received an organ transplant and are taking medicine to suppress the immune system
- Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
People should talk to their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them. The additional dose of an mRNA COVID-19 vaccine should be administered at least four weeks after the second dose of the Pfizer-BioNTech or Moderna vaccine, and the same vaccine should be used. There is not enough data at this time to determine whether immunocompromised people who received the Johnson & Johnson’s Janssen COVID-19 vaccine also have an improved antibody response following an additional dose of the same vaccine.